Table 2.
Before |
After |
||
---|---|---|---|
Staging | n (%) | n (%) | |
IIa | 0 (0.0%) | 2 (5.5%) | |
IIb | 0 (0.0%) | 4 (11.1%) | |
IIIa | 25 (69.4%) | 21 (58.4%) | |
T1-3N2M0 | Bulky N2 | 4 (11.1%) | 1 (2.8%) |
Skipping N2 | 1 (2.8%) | 1 (2.8%) | |
T3N1M0 | 0 (0.0%) | 12 (33.4%) | |
T4N0–1M0 | Vascular invasion | 17 (47.2%) | 4 (11.1%) |
Heart invasion | 2 (5.5%) | 2 (5.5%) | |
Vertebral invasion | 1 (2.8%) | 1 (2.8%) | |
With different lobes of lung metastasis | 0 (0.0%) | 0 (0.0%) | |
IIIb | 11 (30.6%) | 9 (25.0%) | |
T4N2M0 | Vascular invasion | 9 (25.0%) | 7 (19.4%) |
Heart invasion | 1 (2.8%) | 1 (2.8%) | |
Vertebral invasion | 0 (0.0%) | 0 (0.0%) | |
With different lobes of lung metastasis | 1 (2.8%) | 1 (2.8%) |